Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Infectious Diseases and Therapy|August 5, 2019
Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine When Co-Administered with Tetanus-Reduced Diphtheria-Acellular Pertussis and Quadrivalent Meningococcal Conjugate Vaccines in Healthy Adolescents: Results from a Randomized, Observer-Blind, Controlled TrialYan Miao, Thembile Mzolo, Michele Pellegrini
African Journal of AIDS Research : AJAR|April 11, 2015
Determinants of age at sexual debut and associated risks among South African youthsKhangelani Zuma, Thembile Mzolo, Elias Makonko
BMC Public Health|June 9, 2009
Determinants of knowledge of HIV status in South Africa: results from a population-based HIV surveyKarl Peltzer, Gladys Matseke, Thembile Mzolo, et al.
Pharmaceutical Statistics|October 15, 2013
A comparison of statistical methods for combining relative bioactivities from parallel line bioassaysThembile Mzolo, Marga Hendriks, Edwin van den Heuvel
African Journal of Reproductive Health|January 20, 2011
Age at sexual debut: a determinant of multiple partnership among South African youthKhangelani Zuma, Geofrey Setswe, Thabile Ketye, et al.
Pharmaceutical Statistics|November 8, 2017
Equivalence testing for similarity in bioassays using bioequivalence criteria on the relative bioactivityCorine Baljé-Volkers, Thembile Mzolo, Erik Talens, et al.
Vaccine|September 10, 2019
MenACWY-CRM conjugate vaccine booster dose given 4-6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adultsMary Tipton, Wendy Daly, Shelly Senders, et al.
Drug Safety|November 12, 2022
Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety AnalysisPuneet Vir Singh, Paola Tiberi, Gabriele Filippo Di Domenico, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2024
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical StudyTerry Nolan, Chiranjiwi Bhusal, Alejandro Hoberman, et al.
Human Vaccines & Immunotherapeutics|December 16, 2020
Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in childrenMarzia Monica Giuliani, Alessia Biolchi, Pavitra Keshavan, et al.
Pageof 2